ANDA 209708, held by Woodward. Mivacurium Chloride.
As of Nov 16, 2026, ANDA 209708 (Mivacurium Chloride), held by Woodward, was first approved by FDA on Oct 12, 2021, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 12, 2021 | Original application | Approved | None posted |
| Mivacurium ChlorideEQ 10MG BASE/5ML (EQ 2MG BASE/ML) · solution;intravenous | Mivacurium Chloride | Discontinued |
| Mivacurium ChlorideEQ 20MG BASE/10ML (EQ 2MG BASE/ML) · solution;intravenous | Mivacurium Chloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters